Wockhardt now intends to file a new drug application (NDA) with the USFDA and seek marketing authorisation application with ...

Scholar Rock submitted its BLA of apitegromab for the treatment of patients with Spinal Muscular Atrophy with a request for ...

Authorities in many countries are scrambling for solutions to mounting shortages of medicine. Will any of them work?

The Cyprus pulmonology society on Thursday urged Health Minister Michael Damianos to approve a respiratory syncytial virus (RSV) vaccine for use Cyprus. The society also seeks its inclusion into the ...

Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a serious complication.

Zaynich could play a key role in treating patients suffering from complicated urinary tract infections caused by ...

In this article, we will take a look at the 12 stocks that will double in 2025.

Levi Garraway, Roche’s chief medical officer and head of global product development, said: “The INAVO120 overall survival ...

As such, the tech giant is conducting a limited test of ads on Threads with a small number of advertisers, allowing them to extend their existing Meta ad campaigns to the app while the service ...

Sanofi’s Sarclisa (isatuximab) has been approved by the Medicines and Healthcare product Regulatory Agency (MHRA) as part of a combination treatment for newly diagnosed multiple myeloma (MM).

Hastings and Andreas Wicki, PhD Retire from Board of Directors -- PARSIPPANY, N.J., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Pacira ...

To report SUSPECTED ADVERSE REACTIONS, contact Zevra Therapeutics, Inc. at toll-free phone 1-844-600-2237 or FDA at 1‑800-FDA-1088 or www.fda.gov/medwatch.